Engineering ROS-responsive double network hydrogel as bioactive barrier for postoperative abdominal adhesions prevention

工程化ROS响应型双网络水凝胶作为生物活性屏障,用于预防术后腹部粘连。

阅读:1

Abstract

Postoperative adhesions are common and severe complications, which affect up to 90 % of patients undergoing abdominal surgery. Despite the application of various strategies to minimize adhesions, the clinical outcomes remain far from satisfactory. Herein, we engineered a ROS-responsive and scavenging double-network hydrogel (PD-OHN) with multiple biofunctions and good mechanical properties for effective PAA prevention. First, a novel ROS-cleavable dithiothreitol (DTT) crosslinking monomer (DPBA) was synthesized. Subsequently, PD-OHN hydrogel was fabricated within 5 s by forming phenylborate ester bond networks between DPBA and polyvinyl alcohol (PVA), and acylhydrazone bond networks between oxidized hyaluronic acid (OHA) and adipic acid dihydrazide-modified hyaluronic acid (HA-ADH). After spraying, it can form a uniform and stretchable hydrogel film. Results showed that PD-OHN had good mechanical properties with a storage modulus about 20 kPa, satisfactory tissue adhesion strength of approximately 8 kPa, and an appropriate in vivo cecum retention time of about 21 days with good biosafety. More importantly, DPBA in PD-OHN hydrogel scavenged ROS via phenylboronate bond cleavage and the subsequent release of DTT, which intelligently alleviated oxidative stress according to the ROS levels in wound sites and induced pro-inflammatory M1 macrophages to polarize into anti-inflammatory M2 phenotype to alleviate inflammation. Further, the fibrinolytic system balance was recovered and fibrosis was reduced. Consequently, PD-OHN hydrogel effectively prevented adhesion formation in a cecum-sidewall abrasion rat model, and provided a promising whole course care anti-adhesion barrier for effective PAA prevention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。